Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT00505934
Eligibility Criteria:
Inclusion Criteria:
* Male or female between 1 month and 4 years of age, inclusive
* The subject suffers from epilepsy (except status epilepticus)
* The subject is requiring levetiracetam IV treatment in place of oral therapy for a short period of time
Exclusion Criteria:
* The subject has difficult venous accessibility
* History of status epilepticus during the 3 months prior to Screening
* The subject is on felbamate with less than 18 months continuous exposure before Screening.
* The subject presents with current depressive symptoms, current suicidal ideation and/or behavior.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Month
Maximum Age:
4 Years
Study:
NCT00505934
Study Brief:
Protocol Section:
NCT00505934